Citing biomedical documents - National Library of Medicine (NLM) style

Citing parts of conference papers
National Library of Medicine (NLM) style

Patrias K. Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed. Wendling DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007 [updated 2009 Oct 21; cited 2010 Apr 30]. Available from: http://www.nlm.nih.gov/citingmedicine

Components/elements listed in the order they should appear in a reference: (R) = required, (O) = optional

Conference Paper (R) | Name and Number/Letter (R) | Title (R) | Location (Pagination) (R)

  • A table as part of a paper
    • Mueller K, Boye-Beaman J, Blankenau J. Assessing health needs of minorities in rural meat-processing communities. In: Bushy A, editor. Community voices calling us to action. 5th Annual Rural Minority Health Conference Proceedings; 1999 Dec 9-11; Denver, CO. Kansas City (MO): National Rural Health Association; c2000. Table 11, Chi square tests of pap smear by selected independent variables; p. 72.
  • A figure as part of a paper
    • Spigulis J, Erts R, Ozols M. Optical multi-channel monitoring of skin blood pulsations for cardiovascular assessment. In: Cohn GE, Grundfest WS, Benaron DA, Vo-Dinh T, editors. Advanced Biomedical and Clinical Diagnostic Systems 2; 2004 Jan 25-26; San Jose, CA. Bellingham (WA): SPIE; 2004. Figure 6, The four-channel PPG monitoring scheme; p. 137.
  • An appendix as part of a paper
    • Acar J, Rostel B. Antimicrobial resistance: an overview. In: OIE international standards on antimicrobial resistance, 2003. 2nd International Conference on Antimicrobial Resistance; 2001 Oct 2-4; Paris. Paris: OIC; c2003. Appendix B, World Organisation for Animal Health Guidelines on antimicrobial resistance; p. 67.
  • Other parts of a paper
    • Clary J. [Formaldehyde] exposure. In: 1986 European Meeting of the Toxicology Forum; 1986 Sep 22-26; Geneva, Switzerland. Washington: Toxicology Forum, Inc.; c1986. Slide 14, Quantities of some aldehydes in cigarette smoke; [preceding p. 114].
    • Lina PH, Hutson AM. Bat rabies in Europe: a review. In: Dodet B, Schudel A, Pastoret PP, Lombard M, editors. 1st International Conference on Rabies in Europe; 2005 Jun 15-18; Kiev, Ukraine. Basel (Switzerland): Karger; c2006. Bat colonies and rabies; p. 248.
    • Irie S, Shogenji R, Ogura Y, Tanida J. Photonic information techniques based on compound-eye imaging. In: Ijspeert AJ, Masuzawa T, Kusumoto S, editors. Biologically inspired approaches to advanced information technology. BioADIT 2006. Proceedings of the 2nd International Workshop; 2006 Jan 26-27; Osaka, Japan. Berlin: Springer; c2006. [Section] 4.2, Fingerspring capturing; p. 258-9.
  • Part of a paper in a language other than English
    • Morel E, Vialle R, Rillardon L, Guigui. Analyse de l'equilibre sagittal du rachis dans les spondylolisthesis degeneratifs. In: Deburge A, Saillant G, Benoist M, Guigui P, Laville C, Lazennec JY, Morvan G, editors. 2emes Journees du Rachis de Paris = 2nd Spine Meeting of Paris; 2003; Paris. Montpellier (France): Sauramps Medical; c2004. Tableau 4, Comparison du groupe spondylolisthesis (n=53) au group temoin (n=300); p. 112. French.
  • Part of a paper in a language other than English with translation
    • Morel E, Vialle R, Rillardon L, Guigui. Analyse de l'equilibre sagittal du rachis dans les spondylolisthesis degeneratifs [Analysis of the sagittal equilibrium of the spine in degenerative spondylolisthesis]. In: Deburge A, Saillant G, Benoist M, Guigui P, Laville C, Lazennec JY, Morvan G, editors. 2emes Journees du Rachis de Paris = 2nd Spine Meeting of Paris; 2003; Paris. Montpellier (France): Sauramps Medical; c2004. Tableau 4, Comparison du groupe spondylolisthesis (n=53) au group temoin (n=300) [Table 4, Comparison of the spondylolisthesis group (n=53) with the control group (n=300)]; p. 112. French.
  • Part of a paper with title containing a Greek letter or other special character
    • Sheldon RS. β-blockers for prevention of vasovagal syncope: who benefits from treatment? In: Raviele A, editor. Cardiac arrhythmias 2005. Proceedings of the 9th International Workshop on Cardiac Arrhythmias; 2005 Oct 2-5; Venice. Milan (Italy): Springer; c2006. Patient selection for β-blocker therapy; p. 692.
    • or
    • Sheldon RS. Beta-blockers for prevention of vasovagal syncope: who benefits from treatment? In: Raviele A, editor. Cardiac arrhythmias 2005. Proceedings of the 9th International Workshop on Cardiac Arrhythmias; 2005 Oct 2-5; Venice. Milan (Italy): Springer; c2006. Patient selection for beta-blocker therapy; p. 692.
  • Part of a paper with a constructed title
    • Gelepithis PA. Knowledge, truth, time, and topological spaces. In: 12th International Congress on Cybernetics; 1989 Aug 21-29; Namur, Belgium. Namur (Belgium): Association Internationale de Cybernetique; 1989. Appendix, [The basis on which to define a topology on B*]; p. 254.
    • Carter R. Planning for the practical aspects of implementation. In: Pharming the genome: implications of pharmacogenomics for human health and public policy [Internet]. Conference Report; 2004 Nov 4; National Arts Centre, Ottawa, ON. Ottawa (ON): Government of Canada; 2005. [Table, Infrastructure requirements for three types of applications of pharmacogenomics]; p. 20-22. Available from: http://www.biostrategy.gc.ca/CMFiles/50139_Summary_report_e_final49PKA-412005-6986.pdf
    • LeMaire DM. Spirituality. In: Hunter MM, editor. Enriching the circle of care. Report of the 1st National Pediatric Hospice Conference; 1985 May 9-11; Washington, DC. Alexandria (VA): Children's Hospice International; c1985. [Figure, Scheme to describe the spiritual and religious aspects of the human person]; p. 41.
  • Part of a paper with a letter included in the location (pagination)
    • Wolpert C, Haase KK, Suselbeck T, Borggrefe M. Hybrid therapy for atrial fibrillation. In: Capucci A, editor. Proceedings of the European Atrial Fibrillation Consensus Conference; 2001 Sep 16; Bologna, Italy. Amsterdam (Netherlands): Elsevier Science Ltd.; 2003. Figure 1, Concept of hybrid therapy for atrial fibrillation; p. H52.
  • Part of a paper with no page number provided
    • Clary J. [Formaldehyde] exposure. In: 1986 European Meeting of the Toxicology Forum; 1986 Sep 22-26; Geneva, Switzerland. Washington: Toxicology Forum, Inc.; c1986. Slide 14, Quantities of some aldehydes in cigarette smoke; [preceding p. 114].
    • Ross K. The Oregon experience with managed care. In: Groome D, editor. Meeting the challenge of change. Proceedings of the 10th Annual Conference of the National Association of Surveillance and Utilization Review Officials; 1994 Jun 19-22; SeaTac, WA. Olympia (Washington): The Association; 1994. Satisfaction questionnaire; [8 p.]

 
Web www.gfmer.ch

print
Print this page

line

Edited by Aldo Campana,